Emetrol Powder Non-Drowsy

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Emetrol Powder Non-Drowsy
Generic name
SODIUM CITRATE DIHYDRATE
Manufacturer
WellSpring Pharmaceutical Corporation
Product type
HUMAN OTC DRUG
SPL set ID
9d8d2ee7-9db7-4be7-8c73-511eb2e32459
SPL ID
a6121b17-e850-4677-9ad1-ceb36de16336
Version
3
Effective date
2025-01-08
Source export date
2026-10-12
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:10:52
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Ask a doctor before use if you have diabetes because this product contains sugar are on a sodium-restricted diet Ask a doctor or pharmacist before use if you are taking any other medications. This product may interact with certain prescription drugs. When using this product, do not take more than 4 packets in a 24-hour period. Stop use and ask a doctor if nausea lasts more than two weeks or recurs frequently. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.